Due to the wide variety of substrates downstream of the PI3K/AKT pathway and the different types of tumor cells, the anti-tumor effects of luteolin on the PI3K/AKT pathway also vary, but the majority of them are inhibition of cell proliferation and induction of cell apoptosis. The gene discussed is AKT1; the disease is neoplasm.